1312690-16-6

Basic information

• Product Name: N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-cytidine
• Synonyms: N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-cytidine
• CAS NO: 1312690-16-6
• Molecular Weight: 689.997
• Mol File: 1312690-16-6.mol

Chemical Properties

• CAS DataBase Reference: N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-cytidine(CAS DataBase Reference)
• NIST Chemistry Reference: N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-cytidine(1312690-16-6)
• EPA Substance Registry System: N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-cytidine(1312690-16-6)

Safety Data

• Hazardous Substances Data: 1312690-16-6(Hazardous Substances Data)

Upstream product

• 1312690-13-3 2-[(triisopropylsilyl)oxy]-benzyl carbonochloridate 
• 1312690-14-4 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-2',3',5'-tri-O-acetyl-cytidine 
• 1312690-15-5 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-cytidine 
• 56310-18-0 di-tert-butylchlorosilane 
• 13154-24-0 triisopropylsilyl chloride 
• 90-01-7 salicylic alcohol 
• 211617-72-0 (2-{[tris(propan-2-yl)silyl]oxy}phenyl)methanol 

Downstream Products

• 1312690-17-7 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-2'-O-methylthiomethyl-cytidine 
• 1312690-11-1 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-5'-O-(4,4'-dimethoxytrityl)-2'-O-pivaloyloxymethyl-3'-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-cytidine 
• 1312690-23-5 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-5'-O-(4,4'-dimethoxytrityl)-2'-O-pivaloyloxymethyl-cytidine 
• 1312690-21-3 C₃₂H₄₉N₃O₁₀Si 
• 1312690-19-9 N₄-{{{2-[(triisopropylsilyl)oxy]benzyl}oxy}carbonyl}-3',5'-O-di-tert-butylsilanediyl-2'-O-pivaloyloxymethyl-cytidine 

Relevant articles and documents

Synthesis and preliminary evaluation of pro-RNA 2′- O -masked with biolabile pivaloyloxymethyl groups in an RNA interference assay

The cellular delivery of bioactive nucleic acid-based drugs such as small interfering RNA (siRNA) represents a major technical hurdle for their pharmaceutical application. Prodrug-like approaches provide an attractive concept to address the delivery probl